Skip to Content
Publications

Bora Biologics: The Full-Spectrum Biologics Builders

Pharma Tech Outlook,  November 2025.

Bora Biologics Named 2025 Top Microbial Development and Manufacturer

In a recent interview with Pharma Tech Outlook, CEO Stephen Lam shares insights into the company’s role as a premier Contract Development and Manufacturing Organization (CDMO). With dual hubs in San Diego and Zhubei, Bora Biologics excels in transforming biologics from early-stage research to commercial launch. Steve discusses the intricate challenges of scaling production while ensuring regulatory compliance and speed to market.

Bora Biologics combines expertise in microbial and mammalian processes, offering innovative, integrated solutions that enhance efficiency and quality.

Explore how Bora Biologics is shaping the future of biologics, empowering biotech and pharmaceutical clients to bring groundbreaking therapies to market effectively and responsibly.

View PDF

View on PharmaTech Outlook

Bora Biologics

the logical choice

Join the ranks of biopharma pioneers who trust us.
Explore how we minimize risks and accelerate your success.

Partner with us

Client-Centric

100% commitment to supporting your success

We have been the client, bringing multiple biologics from IND to BLA. Your needs and goals are at the forefront of our approach. By involving you in every step of the process, we ensure transparency and alignment, reducing the likelihood of misunderstandings and ensuring the outcome meets your expectations.

Experience

14 years developing & manufacturing biologics

We have honed our ability to navigate complexities. Our track record from concept to commercialization means we can apply best practices and lessons learned, ensuring smoother project execution.

Expertise

125 seasoned scientists & regulatory professionals

Our team exudes deep knowledge and specialized skills. This expertise allows us to foresee potential challenges and implement proactive solutions, reducing the likelihood of setbacks.

Commercial-Ready

US FDA registered GMP manufacturing facility

We focus on delivering solutions that are ready for market. With clinical to commercial scale facilities consistently meeting compliance standards, we ensure your project is primed for success, minimizing the risk of costly revisions or delays.

Allied

access to global CDMO resources

Our partnership with Bora Pharmaceuticals provides additional resources and insights. This network enables us to leverage shared knowledge and expertise, further mitigating risks and accelerating the overall success of your project.